Open Access
CC BY 4.0 · Brazilian Journal of Oncology 2025; 21
DOI: 10.1055/s-0045-1807783
BREAST TUMORS
1839
POSTER PRESENTATION

Pathologic response in er-low early-stage breast cancer treated with neoadjuvant pembrolizumab plus chemotherapy

Authors

  • Renata Colombo Bonadio

  • Flávia Cavalcanti Balint

  • Isadora Martins de Sousa

  • Ana Carolina Marin Comini

  • Monique Celeste Tavares

  • Fernanda Madasi

  • José Bines

  • Rafael Dal Ponte Ferreira

  • Daniela Dornelles Rosa

  • Candice Lima Santos

  • Zenaide Silva de Souza

  • Daniele Assad-Suzuki

  • Júlio Antônio Pereira de Araújo

  • Débora de Melo Gagliato

  • Carlos Henrique dos Anjos

  • Bruna M. Zucchetti

  • Anezka Ferrari

  • Mayana Lopes de Brito

  • Maria Marcela Fernandes Monteiro

  • Renata Cangussu

  • Paulo M. Hoff

  • Maria del Pilar Estevez-Diz

  • Laura Testa

  • Romualdo Barroso-Sousa

Weitere Informationen
  Alle Artikel dieser Rubrik

Keywords

ER-low - breast cancer - immunotherapy - pathologic response


Publikationsverlauf

Artikel online veröffentlicht:
06. Mai 2025

© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)

Thieme Revinter Publicações Ltda.
Rua Rego Freitas, 175, loja 1, República, São Paulo, SP, CEP 01220-010, Brazil

Bibliographical Record
Renata Colombo Bonadio, Flávia Cavalcanti Balint, Isadora Martins de Sousa, Ana Carolina Marin Comini, Monique Celeste Tavares, Fernanda Madasi, José Bines, Rafael Dal Ponte Ferreira, Daniela Dornelles Rosa, Candice Lima Santos, Zenaide Silva de Souza, Daniele Assad-Suzuki, Júlio Antônio Pereira de Araújo, Débora de Melo Gagliato, Carlos Henrique dos Anjos, Bruna M. Zucchetti, Anezka Ferrari, Mayana Lopes de Brito, Maria Marcela Fernandes Monteiro, Renata Cangussu, Paulo M. Hoff, Maria del Pilar Estevez-Diz, Laura Testa, Romualdo Barroso-Sousa. Pathologic response in er-low early-stage breast cancer treated with neoadjuvant pembrolizumab plus chemotherapy. Brazilian Journal of Oncology 2025; 21.
DOI: 10.1055/s-0045-1807783